Neutrophil extracellular trap components and myocardial recovery in post-ischemic acute heart failure

PLoS One. 2020 Oct 29;15(10):e0241333. doi: 10.1371/journal.pone.0241333. eCollection 2020.

Abstract

Objective: The role of neutrophil extracellular traps (NETs) in acute heart failure is unknown. We recently showed that interleukin 8, a putative NETs stimulator, was associated with myocardial recovery in acute heart failure complicating ST-elevation myocardial infarction (STEMI). In this exploratory post-hoc study, we aimed to investigate the role of NETs components in relation to myocardial function and interleukin 8 in STEMI patients with symptomatic acute heart failure.

Methods: In 61 STEMI patients developing acute heart failure within 48 hours of successful revascularization, wall motion score index (WMSI), global longitudinal strain (GLS) and left ventricular ejection fraction (LVEF) were assessed by echocardiography at baseline and on day 5. Blood drawn at baseline and days 1, 2 and 5 was used to quantify double-stranded DNA (dsDNA), myeloperoxidase-DNA complexes (MPO-DNA) and citrullinated histone 3 (CitH3). The area under the curve (AUC) of each NETs marker and interleukin 8 was approximated for the first 5 days.

Results: dsDNAAUC and MPO-DNAAUC correlated significantly with change in WMSI from baseline to day 5 (rs = 0.28 for both, p≤0.05), whereas NETs AUCs did not correlate with changes in GLS and LVEF. dsDNAAUC was significantly correlated with interleukin 8AUC (r = 0.40, p = 0.003). However, mixed model regression could not identify a significant effect of the NETs components on myocardial function parameters.

Conclusions: In this cohort with acute heart failure complicating STEMI, NETs components were partly correlated with myocardial function and interleukin 8 levels, yet no causal relationship between NETs components and myocardial recovery could be established.

Clinical trial registration: ClinicalTrials.gov, identifier: NCT00324766.

Publication types

  • Clinical Trial
  • Observational Study

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • DNA / metabolism
  • Echocardiography
  • Extracellular Traps / metabolism*
  • Female
  • Heart Failure / diagnostic imaging
  • Heart Failure / metabolism*
  • Histones / metabolism
  • Humans
  • Interleukin-8 / metabolism
  • Male
  • Middle Aged
  • Myocardium / metabolism*
  • Peroxidase / metabolism
  • Recovery of Function*
  • ST Elevation Myocardial Infarction / diagnostic imaging
  • ST Elevation Myocardial Infarction / metabolism*

Substances

  • CXCL8 protein, human
  • Histones
  • Interleukin-8
  • DNA
  • MPO protein, human
  • Peroxidase

Associated data

  • ClinicalTrials.gov/NCT00324766

Grants and funding

This work was supported by a PhD grant from the Southern and Eastern Norway Regional Health Authority (grant number 2018025 to ML and IS), as well as the Stein Erik Hagen Foundation for Clinical Heart Research, Oslo, Norway. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.